Vanguard Capital Wealth Advisors Sarepta Therapeutics, Inc. Transaction History

Vanguard Capital Wealth Advisors

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 07, 2024	BUY	$113.33 - $163.85 $3,966 - $5,734	35 Added 1.43%	2,485 $392,000
Q4 2023 Feb 05, 2024	BUY	$67.31 - $124.76 $6,057 - $11,228	90 Added 3.81%	2,450 $236,000
Q3 2023 Nov 01, 2023	BUY	$102.5 - $123.59 $1,025 - $1,235	10 Added 0.43%	2,360 $286,000
Q3 2022 Oct 21, 2022	BUY	$75.71 - $119.24 $177,918 - $280,214	2,350 New	2,350 $260,000
Q1 2022 Apr 29, 2022	SELL	$63.15 - $90.42 $151,560 - $217,008	-2,400 Closed	0 $0
Q3 2021 Nov 01, 2021	BUY	$65.97 - $92.48 $158,328 - $221,952	2,400 New	2,400 $222,000
Q1 2021 Apr 12, 2021	SELL	$72.25 - $168.95 $307,062 - $718,037	-4,250 Closed	0 $0
Q4 2020 Jan 25, 2021	SELL	$125.56 - $178.74 $37,668 - $53,622	-300 Reduced 6.59%	4,250 $729,000
Q2 2020 Aug 05, 2020	SELL	$93.0 - $171.7 $27,900 - $51,510	-300 Reduced 6.19%	4,550 $729,000
Q4 2019 Jan 28, 2020	BUY	$76.53 - $135.58 $49,744 - $88,127	650 Added 15.48%	4,850 $625,000
Q3 2019 Oct 18, 2019	SELL	$72.81 - $156.91 $36,405 - $78,455	-500 Reduced 10.64%	4,200 $316,000
Q4 2018 Jan 17, 2019	SELL	$97.32 - $148.76 $19,464 - $29,752	-200 Reduced 4.08%	4,700 $512,000
Q2 2018 Aug 15, 2018	SELL	$71.74 - $153.69 $7,173 - $15,369	-100 Reduced 2.0%	4,900 $647,000
Q1 2018 Apr 25, 2018	SELL	$54.02 - $82.27 $16,206 - $24,681	-300 Reduced 5.66%	5,000 $0
Q4 2017 Feb 15, 2018	BUY	$47.64 - $56.75 $252,492 - $300,775	5,300	5,300 $0

529

84.2M

2.06M

1.52M

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $10.4B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

Get notified when there are updates to the investment portfolio of Vanguard Capital Wealth Advisors, based on Form 13F filings with the SEC.

Stay updated on Vanguard Capital Wealth Advisors with notifications on news.